These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 20620599)
1. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Kulda V; Pesta M; Topolcan O; Liska V; Treska V; Sutnar A; Rupert K; Ludvikova M; Babuska V; Holubec L; Cerny R Cancer Genet Cytogenet; 2010 Jul; 200(2):154-60. PubMed ID: 20620599 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer]. Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
4. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Kahlert C; Klupp F; Brand K; Lasitschka F; Diederichs S; Kirchberg J; Rahbari N; Dutta S; Bork U; Fritzmann J; Reissfelder C; Koch M; Weitz J Cancer Sci; 2011 Oct; 102(10):1799-807. PubMed ID: 21722265 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening. Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiles in human colorectal cancers with liver metastases. Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058 [TBL] [Abstract][Full Text] [Related]
7. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527 [TBL] [Abstract][Full Text] [Related]
8. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Chen WS; Leung CM; Pan HW; Hu LY; Li SC; Ho MR; Tsai KW Oncol Rep; 2012 Sep; 28(3):1069-76. PubMed ID: 22766685 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of BMP7 in human colorectal cancer. Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples. Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785 [TBL] [Abstract][Full Text] [Related]
11. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896 [TBL] [Abstract][Full Text] [Related]
12. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Akao Y; Nakagawa Y; Hirata I; Iio A; Itoh T; Kojima K; Nakashima R; Kitade Y; Naoe T Cancer Gene Ther; 2010 Jun; 17(6):398-408. PubMed ID: 20094072 [TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Shibuya H; Iinuma H; Shimada R; Horiuchi A; Watanabe T Oncology; 2010; 79(3-4):313-20. PubMed ID: 21412018 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. Navarro A; Marrades RM; Viñolas N; Quera A; Agustí C; Huerta A; Ramirez J; Torres A; Monzo M Oncology; 2009; 76(3):162-9. PubMed ID: 19209007 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710 [TBL] [Abstract][Full Text] [Related]
17. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer. Johnston SJ; Ridge SA; Cassidy J; McLeod HL Clin Cancer Res; 1999 Sep; 5(9):2566-70. PubMed ID: 10499634 [TBL] [Abstract][Full Text] [Related]
18. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Yamamichi N; Shimomura R; Inada K; Sakurai K; Haraguchi T; Ozaki Y; Fujita S; Mizutani T; Furukawa C; Fujishiro M; Ichinose M; Shiogama K; Tsutsumi Y; Omata M; Iba H Clin Cancer Res; 2009 Jun; 15(12):4009-16. PubMed ID: 19509156 [TBL] [Abstract][Full Text] [Related]
19. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307 [TBL] [Abstract][Full Text] [Related]
20. Preoperative tumor markers as prognostic factors of colorectal liver metastases. Treska V; Topolcan O; Stanislav K; Liska V; Holubec L Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]